Anandamide CAS: 94421-68-8

CAS NO: 94421-68-8
Anandamide
Chemical Name: ANANDAMIDE
Molecular Formula: C22H37NO2
Formula Weight: 347.53
CAS No.: 94421-68-8
Description Review
Description

Anandamide, also known as N-arachidonoylethanolamine, is a endocannabinoid and neurotransmitter that plays a key role in various physiological processes. It was first discovered in 1992 and has since been the subject of extensive research due to its potential therapeutic effects.

Chemical Name

The chemical name of Anandamide is N-(2-hydroxyethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide.

Molecular Formula

The molecular formula of Anandamide is C22H37NO2.

Formula Weight

The formula weight of Anandamide is 347.54 g/mol.

CAS No.

The CAS number for Anandamide is 94421-68-8.

Top Ten Keywords and Synonyms from Google

  1. Endocannabinoid
  2. Neurotransmitter
  3. Cannabis-like substance
  4. Cannabinoid receptor agonist
  5. Pain relief
  6. Anti-inflammatory
  7. Mood enhancer
  8. Neuromodulator
  9. Homeostasis
  10. Therapeutic potential

Health Benefits of Anandamide

Anandamide has been shown to have various health benefits, including:

  1. Pain relief: Anandamide can alleviate pain by binding to cannabinoid receptors in the nervous system.
  2. Anti-inflammatory: Anandamide has anti-inflammatory properties, which may be helpful in treating conditions such as arthritis and inflammatory bowel disease.
  3. Mood enhancer: Anandamide has been shown to improve mood and reduce symptoms of anxiety and depression.
  4. Appetite regulation: Anandamide plays a role in regulating appetite and may be helpful in treating eating disorders.
  5. Neuroprotection: Anandamide may protect the brain from damage and improve cognitive function.

Potential Effects

Anandamide has several potential effects, including:

  1. Activation of cannabinoid receptors: Anandamide binds to cannabinoid receptors in the nervous system, producing various physiological effects.
  2. Regulation of homeostasis: Anandamide helps to maintain balance in various physiological processes, including pain sensation, appetite, and mood.
  3. Modulation of synaptic transmission: Anandamide acts as a neuromodulator, influencing the release of other neurotransmitters in the brain.

Product Mechanism

Anandamide works by binding to cannabinoid receptors in the nervous system, primarily CB1 and CB2 receptors. This produces various physiological effects, including pain relief, anti-inflammatory effects, and modulation of mood and appetite. Anandamide is rapidly broken down by enzymes in the body, limiting its duration of action.

Safety

Anandamide is generally considered safe when produced naturally within the body. However, synthetic versions of anandamide have not been extensively studied and may cause adverse effects. Additionally, excessive activation of cannabinoid receptors may lead to undesired effects, including impaired cognition and motor function.

Side Effects

The side effects of anandamide are not well understood, as it is typically produced naturally within the body. However, excessive activation of cannabinoid receptors may lead to impaired cognition and motor function.

Dosing Information

There is no established dosing information for anandamide, as it is typically produced naturally within the body. Synthetic versions of anandamide have not been extensively studied and should only be taken under the guidance of a healthcare professional.

Conclusion

Anandamide is an endocannabinoid and neurotransmitter that plays a key role in various physiological processes. It has potential health benefits, including pain relief, anti-inflammatory effects, and modulation of mood and appetite. Anandamide works by binding to cannabinoid receptors in the nervous system, producing various physiological effects. While generally considered safe when produced naturally within the body, synthetic versions of anandamide have not been extensively studied and may cause adverse effects. If you are considering taking synthetic versions of anandamide, it is important to seek medical attention and follow the guidance of healthcare professionals.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code